Orthofix Medical (FRA:OM2) Cyclically Adjusted FCF per Share: €0.36 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:OM2 Orthofix Medical Inc FRA:OM2
60 GF Score
Price €8.70
GF Value €12.11
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Orthofix Medical Cyclically Adjusted FCF per Share?

Orthofix Medical FRA:OM2 +1.75% 60 Cyclically Adjusted FCF per Share is €0.36 as of Jun. 2026. GuruFocus rates FRA:OM2 with a GF Score™ of 60/100 and a GF Value™ of €12.11 (Modestly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Orthofix Medical's adjusted free cash flow per share for the three months ended in Jun. 2026 was €-0.400. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.36 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Orthofix Medical's average Cyclically Adjusted FCF Growth Rate was -41.20% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -25.80% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -19.30% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was -4.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Orthofix Medical was 20.00% per year. The lowest was -25.80% per year. And the median was -3.15% per year.

As of today (2026-08-21), Orthofix Medical's current stock price is €8.70. Orthofix Medical's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was €0.36. Orthofix Medical's Cyclically Adjusted Price-to-FCF of today is 24.17.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Orthofix Medical was 48.29. The lowest was 9.62. And the median was 25.20.


Orthofix Medical  (FRA:OM2) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Orthofix Medical's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=8.70/0.36
=24.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Orthofix Medical was 48.29. The lowest was 9.62. And the median was 25.20.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Orthofix Medical Cyclically Adjusted FCF per Share Related Terms


Orthofix Medical Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Orthofix Medical's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orthofix Medical Cyclically Adjusted FCF per Share Chart

Orthofix Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.22 1.26 0.83 0.66 0.49

Orthofix Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.51 0.49 0.45 0.36

FRA:OM2 vs VMD, VREX, KIDS: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Orthofix Medical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orthofix Medical Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Orthofix Medical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Orthofix Medical's Cyclically Adjusted Price-to-FCF falls into.


FRA:OM2
60GF Score
Orthofix Medical Inc FRA:OM2
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Orthofix Medical Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Orthofix Medical's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.4/333.9520*333.9520
=-0.400

Current CPI (Jun. 2026) = 333.9520.

Orthofix Medical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 0.636 241.428 0.880
201612 0.868 241.432 1.201
201703 -0.770 243.801 -1.055
201706 0.076 244.955 0.104
201709 0.410 246.819 0.555
201712 1.176 246.524 1.593
201803 -0.301 249.554 -0.403
201806 0.608 251.989 0.806
201809 0.541 252.439 0.716
201812 0.764 251.233 1.016
201903 -0.275 254.202 -0.361
201906 0.186 256.143 0.243
201909 0.345 256.759 0.449
201912 0.297 256.974 0.386
202003 0.353 258.115 0.457
202006 0.612 257.797 0.793
202009 0.810 260.280 1.039
202012 0.750 260.474 0.962
202103 -0.101 264.877 -0.127
202106 -0.299 271.696 -0.368
202109 0.148 274.310 0.180
202112 0.221 278.802 0.265
202203 -0.610 287.504 -0.709
202206 -0.515 296.311 -0.580
202209 -0.343 296.808 -0.386
202212 -0.166 296.797 -0.187
202303 -1.199 301.836 -1.327
202306 -0.460 305.109 -0.503
202309 -0.550 307.789 -0.597
202312 -0.537 306.746 -0.585
202403 -0.717 312.332 -0.767
202406 -0.018 314.175 -0.019
202409 0.137 315.301 0.145
202412 0.375 315.605 0.397
202503 -0.593 319.799 -0.619
202506 0.099 322.561 0.102
202509 0.054 324.800 0.056
202512 0.359 324.054 0.370
202603 -0.605 330.213 -0.612
202606 -0.400 333.952 -0.400

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €0.36 mean?
Orthofix Medical (FRA:OM2) has a Cyclically Adjusted FCF per Share of €0.36 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Orthofix Medical and its competitors.
Is Orthofix Medical's Cyclically Adjusted FCF per Share too high?
Orthofix Medical's current Cyclically Adjusted FCF per Share is €0.36. Overall, Orthofix Medical has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Orthofix Medical's Cyclically Adjusted FCF per Share compare to VMD and VREX?
Orthofix Medical's Cyclically Adjusted FCF per Share of €0.36 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Orthofix Medical and its competitors. Orthofix Medical's current Cyclically Adjusted FCF per Share is €0.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orthofix Medical stock overvalued right now?
Based on GuruFocus' analysis, Orthofix Medical (FRA:OM2) is currently considered Modestly Undervalued. The stock's GF Value™ is €12.11, compared to a current price of €8.70 — trading 28.2% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €0.36. Orthofix Medical's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Orthofix Medical (FRA:OM2), the current Cyclically Adjusted FCF per Share is €0.36 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Orthofix Medical (FRA:OM2) Overvalued in 2026?

Based on GuruFocus' analysis, Orthofix Medical stock appears to be undervalued. The current stock price of €8.70 is trading 28.2% below its estimated GF Value™ of €12.11. GuruFocus considers Orthofix Medical to be Modestly Undervalued.

Key valuation signals for FRA:OM2:

  • Cyclically Adjusted FCF per Share: €0.36
  • GF Value™: €12.11 vs. price of €8.70 (28.2% below fair value)
  • GF Score™: 60/100 with 6 warning signs

No single metric tells the full story. See the FRA:OM2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Orthofix Medical Business Description

Other Exchanges OFIX:USA
Address 3451 Plano Parkway, Lewisville, TX, USA, 75056
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.
60GF Score

Get the complete analysis for FRA:OM2

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.70
Price
€12.11
GF Value